Nexus Pharmaceuticals to build sterile injectable production facility in Wisconsin

US-based healthcare firm Nexus Pharmaceuticals is set to construct a new sterile injectable manufacturing facility in Wisconsin, US.

Nexus has entered into an agreement with Wisconsin’s village Pleasant Prairie for the development of a sterile injectable manufacturing facility.

Expected to be completed in 10 years, the multi-phase and multi-year project is being developed with an estimated investment of around $250m (£200m).

The new facility is being constructed for the production and supply of injectable drug in different therapeutic areas such as anaesthesia, oncology, cardiovascular and neurology.

Nexus Pharmaceuticals CEO Mariam Darsot said: “This investment is needed to drive the continued growth for the U.S. pharmaceutical manufacturing industry.

“We would like to thank the Wisconsin Economic Development Corporation, The Milwaukee 7, Kenosha Area Business Alliance and The Village of Pleasant Prairie for their support as we develop our plans for this major expansion project.”

The company plans to commence phase one construction in August this year and is anticipated to be completed in 2021.

Under the first phase of the project, the company will construct a three-storey manufacturing facility with an investment of around $85m (£68m). The facility will feature an optimised technology, including an advanced isolator system for maximum product protection and sterility.

Nexus will also install multiple lyophilisation (freeze-drying) machines at the facility to support its production of the current portfolio and, as well as generic and specialty injectable drugs.

The company will begin the commercial production in 2022, upon securing approval from the US Food and Drug Administration (FDA) for the facility and manufacturing processes.

Integrated Project Services (IPS) is the designer of the new 100,000ft² facility, while Turner Construction will provide construction management services.

The new facility is expected to create more than 77 new jobs in fields of high-tech manufacturing and science by 2022, said the company.

Pleasant Prairie village president Steinbrink said: “Nexus is a remarkable company with excellent jobs, strong growth and high values. I am confident that Nexus will find Prairie Highlands Corporate Park in Pleasant Prairie to be an exceptional location to grow their business.”

Be the first to comment

Leave a Reply

Your email address will not be published.